AIT Therapeutics Announces Completion of the Agreement to License the Revolutionary Nitric Oxide Generator and Delivery System Pharmaceutical Investing
Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals Pharmaceutical Investing
Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology Biotech Investing
Protalix BioTherapeutics’ pegunigalsidase alfa Receives Fast Track Designation from the U.S. Food and Drug Administration Pharmaceutical Investing
Dermira Initiates Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis Biotech Investing
Vaxil Completes Oversubscribed Financing to Advance Its Cancer Immunotherapy Research and Development Biotech Investing
